Chronic Prostatitis With Chronic Pelvic Pain Syndrome Clinical Trial
Official title:
Analyzing the Brain Alterations of Acupuncture on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome Evaluated by fMRI: Study Protocol for a Randomized Trial
Verified date | January 2023 |
Source | Shanghai University of Traditional Chinese Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is one of the most common diseases in urology, but its pathogenesis remains unclear and the effective therapy lacks. As a kind of chronic pain which the patients suffered for more than 3 months, CP/CPPS could be alleviated by acupuncture. Functional magnetic resonance imaging (fMRI) and higher magnetic field strengths could enable scientists to investigate the brain accurately and non-invasively during every stage of chronic pain.To avoid placebo effect, sham acupuncture would be also enrolled.Herein, by the utilization of fMRI in resting-state, we investigated the influence on patients' brain alterations after the patients accepted the treatment of acupuncture.
Status | Active, not recruiting |
Enrollment | 500 |
Est. completion date | December 31, 2023 |
Est. primary completion date | September 12, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 20 Years to 50 Years |
Eligibility | Inclusion Criteria: (1)The clinical diagnosis of CP/CPPS is exclusionary diagnosis.The main steps of diagnosing CP/CPPS are follwing: T 1. he chief complaint is long-term recurrent pain or discomfort of lumbosacral and perianal distension in the lower abdomen of the external perineum genital area and the superior pubic area (more than 3 months). 2. Bacterial prostatitis will be eliminated by routine culture of prostatic fluid and urine culture before and after prostatic massage. 3. Urinary tract infection will be ruled out by routine urinalysis and sediment examination. (2)Total score of NIH-CPSI = 15. Exclusion Criteria: The participants would be excluded if they got any acute or chronic infectious disease, other chronic pain diseases, internal organic diseases, history of malignant tumors, and chronic diseases that might contribute to peripheral nerve injury like diabetes mellitus and hypertension. Prostate changes will be observed by prostate ultrasound and other urogenital and pelvic space-occupying lesions will be excluded. Contraindications of fMRI scan like claustrophobia and denture implantation status are also considered. |
Country | Name | City | State |
---|---|---|---|
China | Department of Acupuncture, LongHua Hospital, Shanghai University of Traditional Chinese Medicine | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai University of Traditional Chinese Medicine | Huashan Hospital |
China,
Bhatt RR, Gupta A, Mayer EA, Zeltzer LK. Chronic pain in children: structural and resting-state functional brain imaging within a developmental perspective. Pediatr Res. 2020 Dec;88(6):840-849. doi: 10.1038/s41390-019-0689-9. Epub 2019 Dec 2. — View Citation
Chen J, Zhang H, Niu D, Li H, Wei K, Zhang L, Yin S, Liu L, Zhang X, Zhang M, Liang C. The risk factors related to the severity of pain in patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome. BMC Urol. 2020 Oct 7;20(1):154. doi: 10.1186/s12894-020-00729-9. — View Citation
Ge S, Hu Q, Guo Y, Xu K, Xia G, Sun C. Potential Alterations of Functional Connectivity Analysis in the Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Neural Plast. 2021 May 7;2021:6690414. doi: 10.1155/2021/6690414. eCollection 2021. — View Citation
Hopton A, MacPherson H. Acupuncture for chronic pain: is acupuncture more than an effective placebo? A systematic review of pooled data from meta-analyses. Pain Pract. 2010 Mar-Apr;10(2):94-102. doi: 10.1111/j.1533-2500.2009.00337.x. Epub 2010 Jan 8. — View Citation
Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999 Jul 21;282(3):236-7. doi: 10.1001/jama.282.3.236. No abstract available. — View Citation
Park JJ. Developing and validating a sham acupuncture needle. Acupunct Med. 2009 Sep;27(3):93. doi: 10.1136/aim.2009.001495. No abstract available. — View Citation
Passavanti MB, Pota V, Sansone P, Aurilio C, De Nardis L, Pace MC. Chronic Pelvic Pain: Assessment, Evaluation, and Objectivation. Pain Res Treat. 2017;2017:9472925. doi: 10.1155/2017/9472925. Epub 2017 Nov 20. — View Citation
Zhong YM, Luo XC, Chen Y, Lai DL, Lu WT, Shang YN, Zhang LL, Zhou HY. Acupuncture versus sham acupuncture for simple obesity: a systematic review and meta-analysis. Postgrad Med J. 2020 Apr;96(1134):221-227. doi: 10.1136/postgradmedj-2019-137221. Epub 2020 Feb 3. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The change in the NIH-CPSI total score at the end of week 12 and week 36 | The responder is defined as who has a decline of 6 or more than 6-point from baseline measured by using the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) , compared with the baseline in week 0.It is because a decline of at least 6 points in NIH-CPSI is acknowledged as the minimal clinically important difference. The NIH-CPSI is a self-assessment form with nine items, which the main components encompass pain with 4 items focused on location, severity and frequency, urinary function embracing one irritative item and one obstructive item, and quality of life impact with 3 items about the effect of symptoms on daily activities. The NIH-CPSI provides a systematized and unanimously accepted outcome measuring tool, and it is widely used in clinical trials, along with in the evidence-based evaluation of treatment effects. | week 0, week 12 and week 36 | |
Secondary | The alterations in brain of patients with CP/CPPS measured by fMRI when finishing the whole treatment | By analysis of fMRI data, the potential alterations of treatment effect in brain will be concluded. | week 12 | |
Secondary | The alterations in brain of patients with CP/CPPS measured by fMRI in the following-up (24weeks after treatment) | By analysis of fMRI data, the potential alterations of recurrence in brain will be concluded. | week 36 | |
Secondary | the change from baseline in NIH-CPSI subscales | The alterations of NIH-CPSI subscales will provide the certain efficacy in the symptoms of CP/CPPS. | week 0, week 12, week 36 | |
Secondary | the change from baseline in the International Prostate Symptom Score (IPSS) | These changes will reveal the efficacy of acupuncture in the aspect of lower urinary tract symptoms.To detailly describe the symptoms of lower urinary tract, except for the NIH-CPSI, we will independently apply the International Prostate Symptom Score (IPSS). The IPSS covers seven symptom questions and one health-related quality of life (QoL) question. | week 0, week 12, week 36 | |
Secondary | the change from baseline in the Visual Analogue Scale (VAS) | These changes will reveal the efficacy of acupuncture in the aspect of pain.For pain assessment, the Numeric Rating Scale (NRS) is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0 -10 integers) that best reflects the intensity and severity of pain. | week 0, week 12, week 36 | |
Secondary | the change from baseline in the Self-Esteem Scale (SES). | These changes will reveal the efficacy of acupuncture in the aspect of internal self esteem. In 1965, the Self-Esteem Scale (SES) was initially designed to assess adolescents' overall feelings of self-worth and self-acceptance by Rosenberg. The SES contains five positive and five negative items, which is a widely used and well validated measurement with good psychometric properties. | week 0, week 12, week 36 | |
Secondary | the change from baseline in the Social Support Rating Scale (SSRS) | These changes will reveal the efficacy of acupuncture in the aspect of external social support.The Social Support Rating Scale (SSRS) is a questionnaire with 10 items which consists of objective support (3 items), subjective support (4 items) and the utilization of social support (3 items), which assist to evaluate the characteristics of social support and its association with mental health level, mental illness and various physical diseases. The higher score, the more social support. | week 0, week 12, week 36 | |
Secondary | the change from baseline in the Quality of Life(QoL) | These changes will reveal the efficacy of acupuncture in the aspect of subjective life quality feeling. In patients with prostatic diseases, this score is mainly used to evaluate the impact of urination symptoms on quality of life, ranging from very good to very painful, with 0-6 points, to understand the subjective feelings of patients on the level of lower urinary tract symptoms, mainly concerned with the degree of distress caused by lower urinary tract symptoms and whether they can tolerate them. This score is always used within IPSS. | week 0, week 12, week 36 | |
Secondary | the change from baseline in NIH-CPSI | These changes will reveal the efficacy of acupuncture in the aspect of symptoms of CP/CPPS. | week 0, week 12, week 36 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04552431 -
Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and Tamsulosin
|
Phase 2 | |
Not yet recruiting |
NCT05366517 -
Repeating LiST for Refractory Non-bacterial Prostatitis/Pelvic Pain Syndrome
|
N/A | |
Terminated |
NCT02385266 -
Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
|
Phase 4 | |
Completed |
NCT00672087 -
Diagnostic Challenges in IC (and Male CPPS)
|
||
Completed |
NCT03213938 -
Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
N/A | |
Recruiting |
NCT00775515 -
Laparoscopic Prostatectomy for Chronic Prostatitis
|
Phase 2 | |
Completed |
NCT01676857 -
Chemokine Mechanisms in Chronic Pelvic Pain
|
||
Recruiting |
NCT06299683 -
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
|
N/A | |
Completed |
NCT00826514 -
An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis
|
Phase 2 | |
Completed |
NCT06064448 -
Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction
|
Phase 4 | |
Completed |
NCT04446598 -
Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser
|
N/A | |
Completed |
NCT00701311 -
An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
Phase 2 | |
Completed |
NCT04275297 -
Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome
|
N/A | |
Recruiting |
NCT06385977 -
Risk Factors for Chronic Prostatitis Patients in Northwest China
|
||
Completed |
NCT06016595 -
Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients
|
||
Active, not recruiting |
NCT01828996 -
Shocking Therapy for Chronic Pelvic Pain Syndrome
|
N/A | |
Recruiting |
NCT03629769 -
Effects of Proxelan Somministration in Patients With Chronic Prostatitis
|
Phase 3 | |
Recruiting |
NCT06345014 -
The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
Phase 4 | |
Recruiting |
NCT06115083 -
Effects of Pelvic Floor Training in Male Chronic Pelvic Pain, Correlation Between Subjective and Objective Outcomes
|
N/A | |
Completed |
NCT03167216 -
Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction
|
Early Phase 1 |